🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Evandro de Azambuja

Evandro de Azambuja

Université Libre de Bruxelles

ORCID: 0000-0001-9501-4509

Also affiliated with Institut Jules Bordet

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial”.

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

British Journal of Cancer(2020)10.1038/s41416-020-0786-x

N/A

1.4DataRank · unranked

40 citations

Noam Pondé, Dominique Agbor‐Tarh, Alvaro Moreno‐Aspitia, Martine Piccart, Florentine Hilbers +11 more

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)

European Journal of Cancer(2021)10.1016/j.ejca.2021.01.053

N/A

0.685DataRank · unranked

28 citations

Eileen Holmes, Christian Jackisch, Evandro de Azambuja, Frances Boyle, David W. Hillman +37 more

Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis

British Journal of Cancer(2024)10.1038/s41416-023-02501-w

N/A

0.667DataRank · unranked

18 citations

Mariana Carvalho Gouveia, Felippe Lazar Neto, Laura Testa, Paulo Marcelo Hoff, Evandro de Azambuja +2 more

Pregnancy After Breast Cancer in Young BRCA Carriers

JAMA(2024)10.1001/jama.2023.25463

N/A

0.614DataRank · unranked

59 citations

Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim, Antonio Di Meglio +199 more

Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial

Clinical Breast Cancer(2021)10.1016/j.clbc.2021.11.012

N/A

0.413DataRank · unranked

10 citations

Yaohua Ma, Claudia De Angelis, François Richard, Christine Desmedt, Ahmad Awada +7 more

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

Annals of Oncology(2024)10.1016/j.annonc.2024.12.010

N/A

0.208DataRank · unranked

3 citations

Maki Tanioka, Sung Gwe Ahn, Paola Zagami, Tomás Pascual, Mattia Rediti +18 more

Effect of mevalonate pathway inhibitors on outcomes of patients (pts) with HER2-positive early breast cancer (BC) in the ALTTO trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.522

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Lieveke Ameye, Marianne Paesmans, Sarra El-Abed +13 more

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

The Lancet(2023)10.1016/s0140-6736(23)00285-4

N/A

0DataRank · unranked

195 citations

Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető +95 more

Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis

ESMO Open(2023)10.1016/j.esmoop.2023.102031

N/A

0DataRank · unranked

31 citations

Eva Blondeaux, Marco Bruzzone, Maria Maddalena Latocca, Elene Mariamidze, S. Begijanashvili +16 more

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07159-9

N/A

0DataRank · unranked

2 citations

Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni +12 more

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Annals of Oncology(2024)10.1016/j.annonc.2024.06.009

N/A

0DataRank · unranked

28 citations

Marco Bruzzone, R. Bas, Hyun Jin Kim, Antonio Di Meglio, Rinat Bernstein‐Molho +41 more

170P β2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled on the NCCTG-N9831 (Alliance) trial

Annals of Oncology(2020)10.1016/j.annonc.2020.08.292

N/A

0DataRank · unranked

1 citations

Y. Ma, Claudia De Angelis, François Richard, Christine Desmedt, Ahmad Awada +7 more

Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N063D)

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06409-y

N/A

0DataRank · unranked

0 citations

Dominique Agbor‐Tarh, Lissandra Dal Lago, Larissa A. Korde, Florentine Hilbers, Christian Jackisch +9 more

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00452-8

N/A

0DataRank · unranked

13 citations

Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer +15 more